21170 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Treatment of cancer using recall antigens delivered by attenuated bacteria
#302Compositions and methods for producing bacterial conjugate vaccines
#303Mutated
#304Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#305Vaccine compositions against pathogenic fungi and methods for use thereof
#306IBV strains and uses thereof
#307VACCINES FOR PREVENTION AND TREATMENT OF TUBERCULOSIS
#308MSLN targeting DNA vaccine for cancer immunotherapy
#309Tuberculosis vaccine compositions and related methods
#310COMPOSITION AND USES THEREOF
#311Bacteria over-expressing c-di-AMP and therapeutic methods
#312Methods and compositions for attenuated chlamydia as vaccine and vector
#313ATTENUATED VACCINES TO PROTECT AGAINST TICK-BORNE EHRLICHIA SPECIES INFECTIONS
#314METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII
#315Attenuated vaccines and methods of making and use thereof
#316ENGINEERED LISTERIA AND METHODS OF USE THEREOF
#317Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#318Combination Of Listeria-Based Vaccine With Anti-OX40 Or Anti-GITR Antibodies
#319Attenuated bacteria and methods of using
#320MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
#321Attenuated strain which protects against pathogenic infections, vaccine containing and use thereof
#322ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF
#323Vaccine for falciparum malaria
#324Attenuated pasteurella multocida strains
#325Temperature sensitive multivalent vaccines
#326Attenuated strains
#327GENETICALLY MODIFIED BABESIA PARASITES EXPRESSING PROTECTIVE TICK ANTIGENS AND USES THEREOF
#328Attenuated Bordetella strains
#329Global gene regulators (GGR) as vaccine candidates against
#330Mutant strains and methods of use
#331Purified plasmodium and vaccine compositions
#332Vaccine for livestock production systems
#333Naturally-occurring CpG oligonucleotide compositions and therapeutic applications thereof
#334Vaccine for malaria
#335Genetic attenuation of plasmodium by B9 gene disruption
#336GENETICALLY MODIFIED COCCIDIAN PARASITES USEFUL AS VACCINES
#337Attenuated vaccines and methods of making and use
#338RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF
#339RECOMBINANT BACTERIUM AND METHODS OF ANTIGEN AND NUCLEIC ACID DELIVERY
#340Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof
#341Methods of Transforming a Listeria
#342Prevention of using adenylate cyclase deficient strains
#343Dual adjuvant vaccine compositions, preparation and uses
#344Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#345Live bacterial vaccines resistant to carbon dioxide (CO), acidic pH and/or osmolarity for viral infection prophylaxis or treatment
#346Immunological compositions containing attenuated
#347ATTENUATED AND ADAPTED STRAIN OF PSEUDOMONAS FOR DELIVERING ANTIGENS
#348Vaccination compositions, methods of making, and methods of use
#349Influenza Vaccine, Composition, and Methods of Use
#350COMBINATORIAL IMMUNOTHERAPY FOR PANCREATIC CANCER TREATMENT
#351Bacterial vaccine components and uses thereof
#352Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
#353Methods for freeze-drying and rehydrating biologics
#354Needle shaped body and method for manufacturing needle shaped body
#355Combinatorial platform for the display of surface adjuvants and antigens
#356Modified adenoviruses for cancer vaccines development
#357Mesothelin vaccines and model systems
#358GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#359Live attenuated vaccine and method of using the same
#360LIVE SALMONELLA VACCINE AND METHODS TO PREVENT FOWL TYPHOID
#361Compositions comprising angiogenic factors and methods of use thereof
#362Recombinant vaccine strains and methods of producing the same
#363Compositions and methods of preparing Leptospira
#364Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance
#365Compositions and methods for treating or preventing infection
#366Mutated
#367Modified gram positive bacteria and uses thereof
#368Immunogenic compositions comprising
#369Recombinant vaccine strains and methods of using the same in cancer immunotherapy
#370COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#371Attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof
#372Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens
#373Live attenuated catfish vaccine and method of making
#374Compositions and Methods for Treatment of Bacterial Infections
#375Listeria-based adjuvants
#376NOVEL MSLN TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY
#377HEAT-TREATED FORMULATION OF BIFIDOBACTERIUM LACTIS NCC 2818 REDUCES ALLERGIC MANIFESTATIONS
#378Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
#379Interferon-β production modulating strains and methods for using same
#380Fish vaccine
#381Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigens
#382Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
#383Infectious plasmodium sporozoites grown in vitro
#384Tissue targeted antigenic activation of the immune response to treat cancers
#385DNA VACCINE FOR USE IN PANCREATIC CANCER PATIENTS
#386Attenuated strains
#387Live attenuated vaccines
#388Compositions and methods for treatment of cancer using bacteria
#389Live bacterial vectors for prophylaxis or treatment
#390Compositions containing amino acids, phosphate and manganese and their uses
#391Immunogenic formulation containing recombinant live BCG that express antigens of metapneumovirus (hMPV), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use
#392METHODS OF USING RECOMBINANT LISTERIA VACCINE STRAINS IN DISEASE IMMUNOTHERAPY
#393Methods of using presenting N-glycan or derivatives thereof
#394Compositions comprising angiogenic factors and methods of use thereof
#395Attenuated mannheimia haemolytica vaccines and methods of making and use
#396Live-attenuated vaccine against plague
#397Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
#398Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#399Compositions and methods for treatment of cancer using bacteria
#400Campylobacter immunogenic compositions and uses thereof
#401Recombinant as a vaccine
#402VACCINE COMPOSITION
#403IMMUNOGENIC COMPOSITIONS AGAINST TUBERCULOSIS
#404Purified plasmodium and vaccine compositions
#405Methods and compositions using for enhancing immunogenicity by prime boost
#406Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan
#407Pharmaceutical compositions comprising attenuated sporozoites and glycolipid adjuvants
#408Genetically modified babesia parasites expressing protective tick antigens and uses thereof
#409LIVE-ATTENUATED COMPOSITIONS FOR BACTERIAL INFECTIONS
#410Composition and uses thereof
#411Compositions and methods of enhancing immune responses
#412Attenuated bacteria and methods of using
#413Adenylate cyclase deficient bordetella strains
#414Controlled release vaccines and methods of treating diseases and disorders
#415Genetically modified as vaccines against species
#416Methods and compositions for the treatment and/or prophylaxis of associated disease
#417Vaccine for PCV2 and mycoplasma
#418STAPHYLOCOCCUS LIVE CELL VACCINES
#419Methods and compositions for inducing an immune response to EGFRvIII
#420OMV vaccines
#421live vaccine strains and methods of use
#422Method for treating pancreatic cancer with vaccine
#423Fungal immunogens and related materials and methods
#424Bacillus based delivery system and methods of use
#425Attenuated strains
#426Formulations
#427Campylobacter vaccine
#428Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer
#429Method for modulating a bacterial invasion switch
#430USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII
#431Attenuated chlamydia vaccine
#432Modified listeria bacteria and uses thereof
#433COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#434DUAL ADJUVANT VACCINE COMPOSITIONS, PREPARATION AND USES
#435METHODS AND COMPOSITIONS FOR ORALLY DOSING POSTNATAL SWINE
#436Tissue targeted antigenic activation of the immune response to treat cancers
#437Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for associated disease (CDAD)
#438Vaccines for control of epidemic generated by markerless gene deletion
#439Purified plasmodium and vaccine compositions
#440Genetic attenuation of by B9 gene disruption
#441Vectors for transforming , transformed strains, and use thereof
#442Preparation of live vaccines
#443Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
#444Interferon-β production modulating listeria strains and methods for using same
#445GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#446Cross-protecting vaccines
#447Attenuated mutant as a vaccine vector for the delivery of exogeneous antigens
#448Immunological compositions containing attenuated
#449Live attenuated Shigella vaccine
#450MODIFIED BCG STRAINS WITH REDUCED OR ELIMINATED ACTIVITY OF LSR2 AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#451Multifunctional oral vaccine based on chromosome recombineering
#452COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#453Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens
#454Recombinant strains
#455Method of using attenuated bordetella strains
#456Plague vaccine
#457Vaccine vectors and methods of enhancing immune responses
#458Mutant strains of and uses thereof
#459Attenuated fhaC mutants of bacteria and vaccine compositions thereof
#460Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#461Vaccine for protection against disease
#462Live, oral vaccine for protection against serotype 1
#463Combinations of gene deletions for live attenuated shigella vaccine strains
#464DNA vaccine for use in pancreatic cancer patients
#465USE OF ATTENUATED STRAINS OF PARASITES FOR THE PREVENTION OR TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN APICOMPLEXAN
#466METHOD FOR ATTENUATING A BACTERIUM OF THE MYCOBACTERIUM TUBERCULOSIS COMPLEX FOR PRODUCING A TUBERCULOSIS VACCINE
#467ΔESX-3 mutants
#468Recombinant bacterium and uses thereof
#469Attenuated vaccines and methods of making and use thereof
#470Methods and compositions using listeria for enhancing immunogenicity by prime boost
#471Suppressor cell function inhibition following vaccine treatment
#472Compositions comprising angiogenic factors and methods of use thereof
#473Live recombinant booster vaccine against tuberculosis
#474Mucosal immunization to prevent prion infection
#475Methods of transforming a
#476GAS57 mutant antigens and GAS57 antibodies
#477immunogenic compositions and uses thereof
#478Live bacterial vaccines resistant to carbon dioxide (CO), acidic pH and/or osmolarity for viral infection prophylaxis or treatment
#479Attenuated live bacteria with increased acid resistance and methods of use thereof
#480MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
#481Method for producing high yield attenuated strains
#482Immunogenic compositions comprising
#483Vaccine for malaria
#484Attenuated and adapted strain of pseudomonas for delivering antigens
#485Engineered and methods of use thereof
#486Live, attenuated strain and vaccine for protection against pneumococcal disease
#487Compositions Containing Purine and Pyrimidine Nucleosides, Peptides, and Manganese and Their Uses
#488Modified gram-negative bacteria for use as vaccines
#489Methods and compositions for treating cancer
#490Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#491Effect of an attenuated strain against allergic disease
#492Controlled release vaccines and methods for treating diseases and disorders
#493Modified gram positive bacteria and uses thereof
#494Live bacterial vaccines for prophylaxis or treatment of infection
#495Modified live flavobacterium strains, stabilized vaccines comprising same, and methods of making and use thereof
#496Immunization compositions and methods
#497-derived vector and methods of using the same
#498Prevention of recrudescense
#499Listeria-based adjuvants
#500Blood stage malaria vaccine
#501Bacterial RNAs as vaccine adjuvants
#502Interferon-β production modulating strains and methods for using same
#503Attenuated mannheimia haemolytica vaccines and methods of making and use
#504HtrA-defective-derived vaccines
#505Facultatively attenuated bacterial species and methods of preparation and use thereof
#506Pharmaceutical compositions comprising attenuated sporozoites and glycolipid adjuvants
#507Live, oral vaccine for protection against serotype 1
#508Vaccine and drug delivery by intranasal application of vector and vector extracts
#509Mesothelin vaccines and model systems
#510Methods and compositions for inducing an immune response to EGFRvIII
#511Attenuated vaccines and methods of making and use thereof
#512Recombinant bacterium comprising a toxin/antitoxin system
#513Methods and compositions using listeria for adjuvant treatment of cancer
#514Live attenuated catfish vaccine and method of making
#515Vaccines with live bacterial isolates for systemic administration
#516Means of controlling infection persistence of
#517Purified and vaccine composition
#518Methods relating to an attenuated mycoplasma
#519Recombinant microorganisms and uses thereof
#520Synthetic lipid biology for combinatorial engineering of endotoxin
#521Methods and compositions involving protective staphylococcal antigens
#522Purified and vaccine composition
#523Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
#524Avirulent variants and pharmaceutical composition using the same
#525Immunogenic compositions against tuberculosis
#526GAS57 mutant antigens and GAS57 antibodies
#527OMV vaccines
#528Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
#529Oral vaccination of fish with live attenuated vaccines
#530Broad spectrum vaccine against typhoidal and non-typhoidal disease
#531polypeptides and methods of use
#532Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
#533V. Cholera hypereexpressing recombinant cholera toxin B subunit showing dual immunogenicity
#534Vaccine for protection against disease
#535Interferon-β production modulating strains and methods for using same
#536Using Modified Plasmids to Suppress Antibiotic Resistant Pathogens
#537Bacterial vaccine components from and uses thereof
#538vaccine
#539ATTENUATED FISH VACCINE FOLLOWING CULTURE IN IRON LIMITED MEDIA
#540Tuberculosis vaccine
#541Avirulent variants and pharmaceutical composition using the same
#542ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS
#543LIVE BACTERIAL VACCINE SAFETY
#544Nucleic acids encoding GAS57 mutant antigens
#545Bacterium comprising a regulated nucleic acid
#546Methods of transforming a
#547Avirulent variants and pharmaceutical composition using the same
#548PHARMACEUTICAL COMPOSITIONS COMPRISING ATTENUATED PLASMODIUM SPOROZOITES AND GLYCOLIPID ADJUVANTS
#549Leishmania-based carrier for vaccine delivery
#550ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI
#551DNA promoters and anthrax vaccines
#552Multivalent live vector vaccine against -associated disease
#553Vaccine vectors and methods of enhancing immune responses
#554IMMUNOPROTECTION BY ORAL ADMINISTRATION OF RECOMBINANT LACTOCOCCUS LACTIS MINI-CAPSULES
#555Pro-apoptotic bacterial vaccines to enhance cellular immune responses
#556Attenuated live vaccines for aquatic animals
#557Diagnostic, therapeutic and a vaccine against treponemes
#558Ricin ribosome binding protein compositions and methods of use thereof
#559Modified live (JMSO strain) vaccine
#560Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#561Microbial vaccine and vaccine vector
#562Immunogenic composition comprising variants of clumping factor A
#563USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS
#564Modified gram-negative bacteria for use as vaccines
#565Vaccine for Prophylaxis or Treatment of an Allergen-Driven Airway Pathology
#566Strain of s. typhimurium, its use and a method to obtain a therapeutic vaccine vector
#567DNA promoters and anthrax vaccines
#568Anti-bacterial vaccine compositions with a mutated yleA gene
#569Live bacterial vaccines for viral infection prophylaxis or treatment
#570Temperature sensitive vaccine strain of and uses thereof
#571Mycobacterium mutants for vaccines with improved protective efficacy
#572Attenuated FNR deficient enterobacteria
#573LIVE ORGANISM PRODUCT
#574Influenza vaccine, composition, and methods of use
#575Sticky soft gel for treating poultry
#576Engineered listeria and methods of use thereof
#577SALMONELLA MARKER VACCINE
#578Compositions comprising angiogenic factors and methods of use thereof
#579IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION
#580Gamma-glutamyl transpeptidase attenuated
#581presenting N-glycan or derivatives thereof
#582Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof
#583Attenuated enterohemorrhagic -based vaccine vector and methods relating thereto
#584Live-attenuated compositions for bacterial infections
#585GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
#586Use of antigen
#587AUXOTROPHIC RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF IN THE CONTROL OF HUMAN INFECTIONS CAUSED BY PARASITES
#588Recombinant bacterium and methods of antigen and nucleic acid delivery
#589METHOD AND COMPOSITION USING A DUAL SPECIFICITY PROTEIN TYROSINE PHOSPHATASE AS AN ANTIMALARIAL DRUG TARGET
#590Mesothelin vaccines and model systems
#591Bacterial virulence factors and uses thereof
#592Purified plasmodium and vaccine compositions
#593Vaccine for protection against disease
#594Vaccines against tularemia
#595Method for treating cancer with vaccine
#596LIVE ATTENUATED MYCOPLASMA STRAINS
#597LIVE ATTENUATED VACCINES
#598Live, oral vaccine for protection against serotype 1
#599Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
#600DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof